Terra Innovatum Global N.V. Reports Key Corporate Events
Ticker: NKLR · Form: 8-K · Filed: Oct 16, 2025 · CIK: 2067627
Sentiment: neutral
Topics: acquisition, equity-sale, corporate-governance
TL;DR
Terra Innovatum Global N.V. filed an 8-K detailing acquisitions, equity sales, and officer changes.
AI Summary
Terra Innovatum Global N.V. filed an 8-K on October 16, 2025, reporting several key events. These include entering into a material definitive agreement, completing an acquisition or disposition of assets, and unregistered sales of equity securities. The filing also notes material modifications to security holder rights, changes in directors or officers, and amendments to the company's code of ethics. Additionally, it contains Regulation FD disclosures and financial statements.
Why It Matters
This 8-K filing indicates significant corporate actions by Terra Innovatum Global N.V., including acquisitions and equity sales, which could impact its business structure and shareholder value.
Risk Assessment
Risk Level: medium — The filing involves multiple significant corporate events like acquisitions and equity sales, which inherently carry risks and can lead to volatility.
Key Players & Entities
- Terra Innovatum Global N.V. (company) — Filer of the 8-K report
- 20251016 (date) — Filing date of the 8-K
- 20251009 (date) — Period of report for the 8-K
FAQ
What was the nature of the material definitive agreement entered into by Terra Innovatum Global N.V.?
The filing does not specify the details of the material definitive agreement, only that one was entered into.
What specific assets were acquired or disposed of by Terra Innovatum Global N.V.?
The filing indicates the completion of an acquisition or disposition of assets but does not provide specific details about the assets involved.
What were the circumstances surrounding the unregistered sales of equity securities?
The filing confirms unregistered sales of equity securities occurred but does not provide details on the number of shares, price, or recipients.
Were there any changes in the board of directors or executive officers of Terra Innovatum Global N.V.?
Yes, the filing lists 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' as an item of information, indicating potential changes.
What is the business address and phone number for Terra Innovatum Global N.V.?
The business address is VIA DELLA CHIESA XXXII, 759, LUCCA, L6, 55100, and the business phone number is 39-340-465-3058.
Filing Stats: 4,543 words · 18 min read · ~15 pages · Grade level 14.5 · Accepted 2025-10-16 17:05:33
Key Financial Figures
- $12.00 — 1,592,000 ordinary shares of GSR III at $12.00 per share (the "Half Warrants") and war
- $16.00 — o 796,000 ordinary shares of GSR III at $16.00 per share (the "Quarter Warrants", and
- $31.8 million — for an aggregate total of approximately $31.8 million. Subsequent to September 23, 2025, GS
- $4.99 million — for an aggregate total of approximately $4.99 million. The PIPE Warrants, issued in connect
- $5.0 million — bridge loans for gross cash proceeds of $5.0 million (the "Bridge Loans"). The Bridge Loans
- $7.00 — the aggregate, at a conversion price of $7.00 per share. Additionally, in connection
- $11.50 — nts to purchase at an exercise price of $11.50 per share the number of Ordinary Shares
- $15.00 — nts to purchase at an exercise price of $15.00 per share the number of Ordinary Shares
- $690,000 — ns for additional aggregate proceeds of $690,000 having comparable terms as the original
Filing Documents
- ea0261316-8k_terra.htm (8-K) — 171KB
- ea026131601ex3-1_terra.htm (EX-3.1) — 288KB
- ea026131601ex3-2_terra.htm (EX-3.2) — 120KB
- ea026131601ex4-3_terra.htm (EX-4.3) — 47KB
- ea026131601ex10-1_terra.htm (EX-10.1) — 183KB
- ea026131601ex10-3_terra.htm (EX-10.3) — 26KB
- ea026131601ex10-5_terra.htm (EX-10.5) — 21KB
- ea026131601ex14_terra.htm (EX-14) — 60KB
- ea026131601ex21-1_terra.htm (EX-21.1) — 3KB
- ea026131601ex99-1_terra.htm (EX-99.1) — 345KB
- ea026131601ex99-2_terra.htm (EX-99.2) — 27KB
- ea026131601ex99-3_terra.htm (EX-99.3) — 65KB
- ea026131601ex99-4_terra.htm (EX-99.4) — 67KB
- ea026131601ex99-5_terra.htm (EX-99.5) — 40KB
- ea026131601ex99-6_terra.htm (EX-99.6) — 28KB
- ea026131601ex99-7_terra.htm (EX-99.7) — 40KB
- ex3-1_001.jpg (GRAPHIC) — 8KB
- 0001213900-25-099636.txt ( ) — 1965KB
- nklr-20251009.xsd (EX-101.SCH) — 3KB
- nklr-20251009_lab.xml (EX-101.LAB) — 33KB
- nklr-20251009_pre.xml (EX-101.PRE) — 22KB
- ea0261316-8k_terra_htm.xml (XML) — 4KB
Business
Business Combination As disclosed under the sections entitled "The Business Combination Proposal" beginning on page 247 of the proxy statement/prospectus (the "Proxy Statement/Prospectus") filed with the Securities and Exchange Commission (the "SEC") by GSR III on September 16, 2025, Terra Innovatum s.r.l., an Italian limited liability company ("Terra OpCo") entered into a business combination agreement (as amended, the "Business Combination Agreement"), dated April 21, 2025, with GSR III. Pursuant to several transactions contemplated under the Business Combination Agreement, Terra OpCo caused to be formed Terra Innovatum Global s.r.l., an Italian limited liability company (Italian Societ a responsabilit limitata) with the same quotaholders in the same ownership percentages as Terra Opco, ("New TopCo"); New TopCo converted into a limited liability company organized under Dutch law, referred to herein as "Terra"; GSR III was merged with and into GSR III Cayman Merger Sub ( a wholly-owned subsidiary of Terra), with GSR III surviving the merger as a wholly owned subsidiary of Terra (the "Merger" and, together with the other transactions contemplated by the Business Combination Agreement, the "Business Combination"). As previously reported on the Current Report on Form 8-K filed with the SEC on October 14, 2025, GSR III held an extraordinary general meeting of shareholders on October 7, 2025 (the "Special Meeting"), at which GSR III shareholders considered and adopted, among other matters, a proposal to approve the Business Combination, including (a) adopting the Business Combination Agreement and (b) approving the other transactions contemplated by the Business Combination Agreement and related agreements described in the Proxy Statement/Prospectus. Pursuant to the terms and subject to the conditions set forth in the Business Combination Agreement, following the Special Meeting, on October 9, 2025 (the "Closing Date"), the Business Combination was consummated (th
01(f) of Form 8-K provides that if the predecessor registrant
Item 2.01(f) of Form 8-K provides that if the predecessor registrant was a "shell company" (as such term is defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the "Exchange Act")), as GSR III was immediately before the Business Combination, then the registrant must disclose the information that would be required if the registrant were filing a general form for registration of securities on Form 10. Accordingly, the Company is providing the information below that would be included in a Form 10 if it were to file a Form 10. Please note that the information provided below relates to the combined company after the consummation of the Business Combination, unless otherwise specifically indicated or the context otherwise requires. Cautionary Note Regarding Forward-Looking Statements This Report includes statements that express Company's opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, "forward-looking statements." These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms "believes," "estimates," "anticipates," "expects," "seeks," "projects," "intends," "plans," "may" or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this Report (including in information that is incorporated by reference into this Report) and include statements regarding Terra's intentions, beliefs or current expectations concerning, among other things, the results of operations, financial condition, liquidity, prospects, growth, and strategies of Terra and the markets in which Terra operates. Such forward-looking statements are based on available current market material and management's expectations, beliefs and forecasts concernin
Business
Business Terra's business is described in the Proxy Statement/Prospectus in the section titled " Business of Terra Innovatum " beginning on page 154, which is incorporated herein by reference. Risk Factors The risks associated with Terra's business are described in the Proxy Statement/Prospectus in the section titled " Risk Factors " beginning on page 23 and are incorporated herein by reference. A summary of the risks associated with Terra's business is also included beginning on page 18 of the Proxy Statement/Prospectus under the heading "Summary Risk Factors" and are incorporated herein by reference. 4 Financial Information The audited financial statements of GSR III as of December 31, 2024 and 2023 and for the year ended December 31, 2024 and for the period from May 10, 2023 (inception) through December 31, 2023 are included in the Proxy Statement/Prospectus beginning on page F-19, which are incorporated herein by reference. The audited financial statements of Terra Opco as of December 31, 2024 and 2023 and for the years ended December 31, 2024 and 2023 are included in the Proxy Statement/Prospectus beginning on page F-37, which are incorporated herein by reference. The audited financial statements of New TopCo as of April 29, 2025 and for the period beginning April 29, 2025 (inception) and ended April 29, 2025, are included in the Proxy Statement/Prospectus beginning on page F-68, which are incorporated herein by reference. The unaudited financial statements of GSR III as of June 30, 2025 and for the periods ended June 30, 2025 and 2024 are included in the Proxy The unaudited consolidated financial statements of New TopCo as of June 30, 2025 and for the periods ended June 30, 2025 and 2024 are included in the Proxy Statement/Prospectus beginning on page F-51, which are incorporated herein by reference. The unaudited pro forma condensed combined financial i
Properties
Properties The Company's headquarters is located in Lucca, Italy. Its workplace is described in the Proxy Statement/Prospectus in the section titled " Information About Terra Innovatum –Human Capital " on page 164 and that information is incorporated herein by reference. 5 Security The following table sets forth information known to us regarding the beneficial ownership of our Ordinary Shares immediately following consummation of the Transactions by: each person who is the beneficial owner of more than 5% of the outstanding shares of our Ordinary Shares; each of our named executive officers and directors; and all of our executive officers and directors as a group. Beneficial if he, she or it possesses sole or shared voting or investment power over that security, including options and warrants that are currently exercisable or exercisable within 60 days. Except as described in the footnotes below and subject to applicable community property laws and similar laws, we believe that each person listed above has sole voting and investment power with respect to such shares. The beneficial ownership of our Common Stock is based on (i) 70,300,948 ordinary shares issued and outstanding immediately following consummation of the Transactions, (ii) 1,000,000 PubCo Ordinary Shares potentially issuable to PAC upon the exercise of a warrant issued upon the Closing of the Business Combination, (iii) 1,702,966 PubCo Ordinary Shares potentially issuable upon the exercise of warrants issued upon the Closing of the Business Combination to certain Bridge Loan lenders, and (iv) 2,762,625 PubCo Ordinary Shares potentially issuable to the PIPE Financing subscribers upon the exercise of the PIPE Warrants issued upon the Closing of the Business Combination. All such warrants are exercisable